171 results on '"Amer, Radgonde"'
Search Results
2. Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series
- Author
-
Pillar, Shani, Weinberg, Tamar, and Amer, Radgonde
- Published
- 2023
- Full Text
- View/download PDF
3. The Humira in Ocular Inflammations Taper (HOT) Study
- Author
-
Pichi, Francesco, Smith, Scott D., Goldstein, Debra A., Baddar, Dina, Gerges, Terese K.A., Janetos, Timothy M., Ruiz-Cruz, Matilde, Elena Concha-del-Río, Luz, Maruyama, Kazuichi, Carina ten Berge, Josianne, Rombach, Saskia M., Cimino, Luca, Bolletta, Elena, Miserocchi, Elisabetta, Scandale, Pierluigi, Serafino, Massimiliano, Camicione, Paola, Androudi, Sofia, Gonzalez-Lopez, Julio J., Lim, Lyndell L., Singh, Nandini, Gupta, Vishali, Gupta, Nikita, Amer, Radgonde, Dodds, Emilio M., Inchauspe, Sebastian, Munk, Marion R., Donicova, Emilia, Carreño, Ester, Takeuchi, Masaru, Chee, Soon-Phaik, Chew, Milton C., Agarwal, Aniruddha, Schlaen, Ariel, Gómez, Ramiro A., Couto, Cristobal A., Khairallah, Moncef, and Neri, Piergiorgio
- Published
- 2024
- Full Text
- View/download PDF
4. The effect of pregnancy on the course of uveitis in single and multiple pregnancies
- Author
-
Sharon, Yael, Adler, Avital, Tiosano, Alon, Sanchez, Juan M., Amer, Radgonde, and Kramer, Michal
- Published
- 2023
- Full Text
- View/download PDF
5. Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis
- Author
-
Shmueli, Or and Amer, Radgonde
- Published
- 2022
- Full Text
- View/download PDF
6. Endophthalmitis panorama in the Jerusalem area
- Author
-
Sanchez, Juan Martin, Elinav, Hila, Tiosano, Liran, and Amer, Radgonde
- Published
- 2022
- Full Text
- View/download PDF
7. Autoimmune retinopathy: clinical, electrophysiological, and immunological features in nine patients with long-term follow-up
- Author
-
Safadi, Khaled, Chowers, Itay, Banin, Eyal, Rosin, Boris, Tiosano, Liran, and Amer, Radgonde
- Published
- 2022
- Full Text
- View/download PDF
8. Increased Risk of Celiac Disease in Patients with Uveitis.
- Author
-
Milstein, Yosef, Haiimov, Elianora, Slae, Mordechai, Davidovics, Zev, Millman, Peri, Birimberg-Schwartz, Liron, Benson, Ariel, Wilschanski, Michael, and Amer, Radgonde
- Subjects
CELIAC disease ,ANTIBODY titer ,NON-communicable diseases ,ISRAELIS ,ODDS ratio - Abstract
Purpose: To examine whether patients with non-infectious uveitis (NIU) are at increased risk for celiac disease (CeD). Methods: Celiac antibody testing was completed in 112 patients. The control group included patients who had undergone upper endoscopy for suspicion of CeD. Results: 2/112 (1.79%) of patients with NIU had positive anti-tTG serology and CeD was confirmed in both patients. When compared to the expected risk of CeD in the general Israeli population of 0.31%, this corresponded to an odds ratio of 5.77 (95% CI 1.4118 to 23.4737, P = 0.049). Three additional patients had positive serology for CeD but the diagnosis was not confirmed. Conclusions: An increased risk of CeD was detected in patients with NIU. We therefore recommend screening for CeD in NIU patients. Larger prospective studies are required to further validate these results. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Long-term Experience with Anti-tumor Necrosis factor - α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior, and Panuveitis.
- Author
-
Corredores Dieb, Jamel, Vofo, Brice, and Amer, Radgonde
- Subjects
EYE inflammation ,TUMOR necrosis factors ,BIOTHERAPY ,VISUAL acuity ,CHRONOBIOLOGY - Abstract
To study the efficacy and long-term effects of infliximab and adalimumab in patients with active refractory non-infectious intermediate, posterior, or panuveitis (NIPPU). Retrospective, longitudinal study. Included were 61 patients (104 eyes) of whom 34 were males (55.74%). Mean age at diagnosis of uveitis was 26.5 ± 16.14 years. All patients had active uveitis at baseline (time of initiation of biological therapy). Median interval between the start of conventional immunomodulatory therapy (IMT) to the introduction of biological therapy was 13.0 (IQR 26.0) months. Ocular inflammation was effectively controlled in 92 eyes (88.46%). The most commonly used TNF-α inhibitor was adalimumab in 47 patients (77%). Mean follow-up time after baseline was 40 ± 34.08 months. In the year preceding the institution of TNF-α inhibitors, the average number of flares was 1.5 ± 1.1/year and it decreased to 0.08 ± 0.29/year in the first year after baseline (p <.0005). Forty-four eyes (42.30%) experienced flare over the entire follow-up period. Mean time to first flare was 14.5 ± 9.26 months. At baseline, the mean dose of prednisone was 25.5-±20.8 mg/day. A marked decrease to a mean prednisone dose of 7.85 ± 9.7 mg/day was observed at 6 months (p =.03). In patients treated with adalimumab, the mean time to prednisone dose ≤7.5 mg/day was 4.02 ± 4.89 months compared to 15.64 ± 21.34 months in patients treated with infliximab (p =.03). 64.3% of patients treated by infliximab had Behçet uveitis compared to 27.7% of patients treated by adalimumab. Eyes treated with adalimumab experienced first flare at a mean time of 14.11 ± 6.29 months, whereas eyes treated with infliximab experienced first flare at 18.29 ± 14.24 months after baseline (p <.0005). The risk for moderate and severe visual loss was lower with shorter duration of uveitis before initiating anti-TNF-α treatment (odds ratio, 0.003; 95% CI, 0.000–0.005; p =.023), better presenting logMAR VA (odds ratio, 0.266; 95% CI, 0.172–0.361; p <.0005) and when adalimumab was used (odds ratio, 0.354; 95% CI, 0.190–0.519, p <.0005). Anti-TNF-α therapy was successful in controlling refractory NIPPU in the majority of cases. It significantly reduced flare rate, exerted steroid-sparing effects, and preserved visual potential. Adalimumab use, better initial visual acuity, and earlier introduction of anti-TNF- α therapy were associated with a lower risk of visual loss. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Anti-tumor necrosis factor-alpha therapy for refractory uveitic optic disk neovascularization in active non-infectious posterior and panuveitis
- Author
-
Amer, Radgonde and Cohen, Oren
- Published
- 2021
- Full Text
- View/download PDF
11. Ocular Complications of Intermediate Uveitis.
- Author
-
Amer, Radgonde and Sharon, Yael
- Subjects
- *
POSTERIOR segment (Eye) , *ANTERIOR eye segment , *VITRECTOMY , *UVEITIS , *EYE inflammation , *OCULAR hypotony , *PROLIFERATIVE vitreoretinopathy , *OPTIC neuritis - Abstract
Intermediate uveitis (IU) in an intraocular inflammation that predominantly affects the vitreous. It typically manifests as chronic low-grade inflammation, mainly affecting children and young adults. Uncontrolled chronic intraocular inflammation carries a high risk of visual loss. IU, despite being a low-grade inflammation, is among the sight-threatening conditions owing to its intrinsically-associated vision-robbing ocular complications. It can cause early and late-onset ocular complications affecting the anterior and posterior segments of the eye. 40–60% of the patients who suffer from IU will develop at least one ocular complication during the disease course. Prompt management and long-term monitoring are vital for the early detection of ocular complications and timely intervention. Proactive screening programs are essential in children because of the occult nature of IU in the pediatric age group and the high prevalence of complications at the initial visit. This review provides a comprehensive panorama of anterior segment complications, namely, band keratopathy, corneal endotheliopathy, posterior synechiae, and cataract as well as of posterior segment complications including macular edema, retinoschisis, retinal detachment, vitreous hemorrhage, vasoproliferative tumor, optic neuritis, and papillitis, in addition to glaucoma and hypotony. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. The Spectrum of Papillophlebitis.
- Author
-
Abdel Jalil, Sara and Amer, Radgonde
- Abstract
PurposeMethodsResultsConclusionPapillophlebitis is a rare condition, manifesting as CRVO in the young adults. We aim to present our experience in managing patients with papillophlebitis.Retrospective review of patients’ medical files.Included were seven patients with a mean presenting age of 24.86 ± 4.4 years and mean follow-up of 40.4 ± 50.5 months. No pre-existing systemic illness was reported by any patient. One patient was subsequently diagnosed to have Behçet disease and another patient was diagnosed with homozygous mutation to MTHFR C6771. On presentation, fluorescein angiograms showed diffuse vascular and optic disc leakage. Four patients presented with papillophlebitis-associated CME, for which they were treated with systemic steroids and intravitreal anti-VEGF injections. One patient showed full recovery. In 3 patients, due to the protracted course of papillophlebitis and refractory CME, adalimumab was added. All 3 patients eventually showed complete resolution of CME. Two of them eventually developed extensive peripheral capillary non-perfusion that was treated with panretinal photocoagulation. Three patients did not develop CME: In two patients, papillophlebitis resolved after a short course of prednisone while in the third patient, papillophlebitis resolved spontaneously. Mean ± SD presenting log MAR VA was 0.2 ± 0.32 and it was 0.057 ± 0.11 at the last follow-up.To the best of our knowledge, this is the first description that suggests a role for TNF-ɑ blockers in the management of patients with recalcitrant papillophlebitis and non-responsive CME. Further studies are needed in order to thoroughly investigate the molecular background of papillophlebitis and clinical outcomes associated with this class of medications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis.
- Author
-
Merzbach, Shira, Hoffman, Amnon, Lazarovici, Philip, Gilon, Chaim, and Amer, Radgonde
- Subjects
UVEITIS ,DRUG therapy ,T cells ,THIOUREA ,PEPTIDE synthesis ,CALCIUM-binding proteins ,LEAD compounds ,ALLELES ,CALCIUM channels - Abstract
We describe the design, synthesis, and activity of a potent thiourea-bridged backbone cyclic peptidomimetic known as Clarstatin, comprising a 5-amino acid sequence (Q/D)
1 -(R/K)2 -X3 -X4 -A5 -(Gln/Asp)1 -(Arg/Lys)2 -AA3 -AA4 -Ala5 -based on a motif called "shared epitope (SE)", specifically present in specific alleles of the HLA-DRB1 gene. This SE binds to a particular site within the proline reach domain (P-domain) of the cell surface-calreticulin (CS-CRT). CS-CRT is a multifunctional endoplasmic reticulum (ER) calcium-binding protein that is located on the cell surface of T cells and triggers innate immune signaling, leading to the development of inflammatory autoimmune diseases. The development of Clarstatin was based on the parent peptide W-G-D1 -K2 -S3 -G4 -A5 - derived from the active region of the SE. Following the design based on the cycloscan method, the synthesis of Clarstatin was performed by the Fmoc solid phase peptide synthesis (SPPS) method, purified by HPLC to 96% homogeneity, and its structure was confirmed by LC-MS. Clarstatin reduced calcium levels in Jurkat lymphocyte cultures, ameliorated uveitis in vivo in the experimental autoimmune uveitis (EAU) mice model, and was safe upon acute toxicity evaluation. These findings identify Clarstatin as a promising lead compound for future drug development as a novel class of therapeutic agents in the therapy of uveitis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
14. Aqueous humor perturbations in chronic smokers: a proteomic study.
- Author
-
Amer, Radgonde and Koriat, Adi
- Subjects
- *
AQUEOUS humor , *ACUTE phase proteins , *PROTEOMICS , *MACULAR degeneration , *BLOOD proteins , *PEPTIDASE , *OXYGEN carriers - Abstract
The detrimental effects of smoking are multisystemic and its effects on the eye health are significant. Smoking is a strong risk factor for age-related nuclear cataract, age-related macular degeneration, glaucoma, delayed corneal epithelial healing and increased risk of cystoid macular edema in patients with intermediate uveitis among others. We aimed to characterize the aqueous humor (AH) proteome in chronic smokers to gain insight into its perturbations and to identify potential biomarkers for smoking-associated ocular pathologies. Compared to the control group, chronic smokers displayed 67 (37 upregulated, 30 downregulated) differentially expressed proteins (DEPs). Analysis of DEPs from the biological point of view revealed that they were proteins involved in complement activation, lymphocyte mediated immunity, innate immune response, cellular oxidant detoxification, bicarbonate transport and platelet degranulation. From the molecular function point of view, DEPs were involved in oxygen binding, oxygen carrier activity, hemoglobin binding, peptidase/endopeptidase/cysteine-type endopeptidase inhibitory activity. Several of the upregulated proteins were acute phase reactant proteins such as clusterin, alpha-2-HS-glycoprotein, fibrinogen, alpha-1-antitrypsin, C4b-binding protein and serum amyloid A-2. Further research should confirm if these proteins might serve as biomarkers or therapeutic target for smoking-associated ocular diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children
- Author
-
Navarrete, Ana, Koriat, Adi, and Amer, Radgonde
- Published
- 2020
- Full Text
- View/download PDF
16. Lens-induced uveitis: an update
- Author
-
Nche, Eleanor Ngwe and Amer, Radgonde
- Published
- 2020
- Full Text
- View/download PDF
17. Vasoproliferative Tumor Secondary to Sarcoidosis-Associated Intermediate Uveitis.
- Author
-
Jalil, Sara Abdel, Jaouni, Tareq, and Amer, Radgonde
- Subjects
RETINAL disease diagnosis ,SARCOIDOSIS diagnosis ,STEROID drugs ,ONCOLOGIC surgery ,CANCER complications ,CANCER diagnosis ,UVEITIS ,RETINAL detachment ,COMBINATION drug therapy ,VISION disorders ,RETINAL diseases ,OPTICAL coherence tomography ,INTRAVITREAL injections ,CYCLOSPORINE ,SARCOIDOSIS ,TREATMENT effectiveness ,ANGIOGRAPHY ,COLD therapy ,VISUAL acuity ,DISEASE relapse ,OPHTHALMIC surgery ,GLUCOCORTICOIDS ,DISEASE complications - Abstract
We report the visual and clinical outcomes of a middle-aged woman who presented with exudative retinal detachment (ERD) secondary to a vasoproliferative tumor (VPT) in an eye with sarcoidosis-associated intermediate uveitis. A 55-year-old woman previously diagnosed with sarcoidosis presented with decreased vision in the left eye (LE). Visual acuity in the LE was counting fingers. She had active vitritis, and a peripheral retinal vascular mass was noted in the superotemporal periphery. The mass was associated with ERD involving the posterior pole. The patient was managed with systemic and intravitreal steroids, and cyclosporine was subsequently added as a steroid-sparing agent. Because of recurrence of ERD, the patient underwent pars plana vitrectomy, and cryotherapy and laser photocoagulation were applied to the VPT. Two months postoperatively, visual acuity in the LE improved to 6/10. There was marked regression of the VPT and total resolution of the ERD. In conclusion, we report a favorable visual and clinical outcome in a patient with VPT-associated ERD who responded to a combination of medical therapy and surgical intervention. VPT may lead to different remote complications, so timely diagnosis of these tumors and proper management of their complications is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Long-term follow-up of a healthy man with endogenous Streptococcus anginosus endophthalmitis.
- Author
-
Sanchez, Juan Martin, Davila, Mauricio, Halpert, Michael, and Amer, Radgonde
- Subjects
IRIDOCYCLITIS ,STREPTOCOCCUS ,ENDOPHTHALMITIS ,PARS plana ,VISUAL acuity ,INTRAOCULAR pressure - Abstract
We report the long-term follow-up of an immunocompetent patient who presented with slowly progressive endogenous endophthalmitis secondary to Streptococcus anginosus. A 46-year-old healthy man presented with a two-month history of right eye iritis. On examination, visual acuity was 20/60 with intraocular pressure of 6 mm Hg. There was a small layer of hypopyon with non-granulomatous anterior uveitis and vitritis. On funduscopy, fluffy white peripheral retinal and pre-retinal lesions were noted in superonasal periphery. The patient denied any present or past illness. Diagnostic pars plana vitrectomy was performed. Culture and polymerase chain reaction of the vitreous sample were positive for Streptococcus anginosus. Intravitreal vancomycin and ceftazidime and systemic ceftriaxone were administered. Work-up which included blood and urine cultures, chest x-ray, echocardiography and abdominal ultrasound was unyielding. Subsequently and because of persistent post-infectious inflammatory reaction, intravitreal and oral steroids were administered in addition to oral azathioprine later on. After one year of follow-up, visual acuity was 20/20 with near vision of Jaeger 3 + and no signs of active uveitis were seen. Therefore, Streptococcus anginosus should be considered in the differential diagnosis of a slowly progressive endophthalmitis also in immunocompetent individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Long-term clinical outcomes of patients with sympathetic ophthalmia.
- Author
-
Mavris, Neofytos and Amer, Radgonde
- Abstract
Purpose: To present the long-term clinical outcomes of patients with sympathetic ophthalmia (SO). Methods: Retrospective review of patients’ medical files between 2002 and 2022. Results: Included were seven patients (four males). The mean ± SD age at presentation was 37.9 ± 22.5 years. Four patients had co-morbidities: three had diabetes mellitus type 2 and one had Turner Syndrome. Trauma was the inciting event in six patients and postoperative endophthalmitis in one patient. Decreased visual acuity (VA) was the leading symptom in the sympathizing eye and all of the patients presented with panuveitis. The mean ± SD interval between the triggering incident and the onset of SO in six cases was 4.3 ± 4.2 months. One case presented 30 years following the eye injury. Five patients underwent enucleation/evisceration of the exciting eye. The mean ± SD presenting LogMAR BCVA in the sympathizing eye was 0.57 ± 0.82, and the final LogMAR BCVA was 0.61 ± 0.95. Inflammation was completely controlled in 5 patients at a mean ± SD of 8.55 ± 9.21 months following the institution of immunomodulatory therapy, and it was partially controlled in 2 patients. VA deteriorated in all 3 diabetic patients and improved or remained stable in the 4 young and healthy patients. The mean ± SD follow-up period after achieving drug-free remission was 28 ± 22.8 months. The mean ± SD follow-up time was 6.8 ± 5.6 years. Conclusions: SO is one of the most sight-threatening conditions, affecting the healthy eye. In this cohort, the favorable visual outcome was especially seen in young and healthy individuals. Visual prognosis is directly related to prompt diagnosis and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS
- Author
-
Pichi, Francesco, Neri, Piergorgio, Agarwal, Aniruddha, Invernizzi, Alessandro, Choudhry, Netan, Amer, Radgonde, Lembo, Andrea, Nucci, Paolo, Thompson, Ian, Sen, H. Nida, and Shields, Carol L.
- Published
- 2019
- Full Text
- View/download PDF
21. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies
- Author
-
Deitch, Iris, Amer, Radgonde, Tomkins-Netzer, Oren, Habot-Wilner, Zohar, Friling, Ronit, Neumann, Ron, and Kramer, Michal
- Published
- 2018
- Full Text
- View/download PDF
22. Pattern and causes of visual loss in Behçet’s uveitis: short-term and long-term outcomes
- Author
-
Amer, Radgonde, Alsughayyar, Walaa, and Almeida, Diego
- Published
- 2017
- Full Text
- View/download PDF
23. Bilateral Endogenous Methicillin-Resistant Staphylococcus aureus Endophthalmitis in a Young Athlete: A Story of Full Recovery
- Author
-
Corredores, Jamel, Halpert, Michael, Cohen, Oren, and Amer, Radgonde
- Subjects
Male ,endogenous endophthalmitis ,vitrectomy ,Case Report ,Recovery of Function ,methicillin-resistant staphylococcus aureus ,Staphylococcal Infections ,RE1-994 ,Eye Infections, Bacterial ,Anti-Bacterial Agents ,Methicillin ,Young Adult ,Ophthalmology ,endophthalmitis ,Athletes ,Vancomycin ,Humans ,Medicine - Abstract
Endogenous endophthalmitis (EE) is an ophthalmological emergency. We report the long-term outcome of bilateral methicillin-resistant Staphylococcus aureus EE in a 23-year-old healthy immunocompetent athlete who presented with EE secondary to pelvic abscess and remained with excellent vision.
- Published
- 2021
24. Ophthalmic manifestations of bartonella infection
- Author
-
Amer, Radgonde and Tugal-Tutkun, Ilknur
- Published
- 2017
- Full Text
- View/download PDF
25. Frosted branch angiitis complicated by retinal vein occlusion: clinical course and long-term visual outcome
- Author
-
Greifner, Gabriel, Neri, Piergorgio, and Amer, Radgonde
- Published
- 2016
- Full Text
- View/download PDF
26. Enhanced S-Cone Syndrome Masquerading as TORCH in an Infant and a Toddler.
- Author
-
Navarrete, Ana, Matanis-Suidan, Milka, Hemo, Itzhak, Mechoulam, Hadas, Banin, Eyal, and Amer, Radgonde
- Subjects
TODDLERS ,INFANTS ,POLYPOIDAL choroidal vasculopathy ,GENETIC testing ,OCULAR manifestations of general diseases ,TORCHES ,STRABISMUS - Abstract
To report two cases masquerading as TORCH but eventually diagnosed with Enhanced S-cone Syndrome (ESCS). Descriptive case report Case 1: A ten-month-old boy presented with high hypermetropia, strabismus and bilateral chorioretinal pigmented scars with a history of cat scratch of his mother during pregnancy. He was treated for suspected toxoplasma retinitis. Choroidal neovascular membranes (CNV) were diagnosed bilaterally and treated with intravitreal bevacizumab. Genetic testing showed homozygote mutation in NR2E3 gene. Case 2: A two-year old girl presented with bilateral high hypermetropia and strabismus. Funduscopy revealed extrafoveal chorioretinal lesions and surrounding subretinal fibrosis. An elevated titer of anti-toxocara IgG antibodies was detected and managed accordingly. LE CNV was diagnosed and treated with intravitreal bevacizumab. Genetic testing disclosed homozygote mutation in NR2E3. Ocular manifestations in ESCS can be reminiscent to TORCH. CNV may develop with an incidence of 15%. We report the youngest patient with ESCS-associated CNV. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Uveitis in Children: The Role of Biological Agents in Its Management.
- Author
-
Corredores, Jamel, Vofo, Brice, and Amer, Radgonde
- Subjects
IRIDOCYCLITIS ,UVEITIS ,VISUAL acuity ,BIOTHERAPY ,JUVENILE idiopathic arthritis - Abstract
We aimed to determine medium and long-term effects of TNF-α inhibitors in patients with pediatric uveitis. This was a retrospective review of medical charts. Included were 50 patients (84 eyes). Mean age at diagnosis was 7.22 ± 4.04 years. At baseline (time of initiation of biologic therapy), all patients had active uveitis. Complete control of uveitis was achieved in 84.52% (n = 71) of eyes, after a median of 3 months (IQR 2 months). Mean LogMAR BCVA at baseline was 0.23 ± 0.44; it remained stable at 12 and 24 months. At baseline, 64% of patients were treated with oral corticosteroids, this decreased to 29.5% at 12 months (p = 0.001) and to 21.9% at 24 months (p < 0.001). Mean time to prednisone dose of ≤0.2 mg/kg/day was 8.1 ± 2.02 months after baseline. A total of 40.5% of eyes were treated with topical steroids at baseline and this significantly decreased to 5.8% at 12 months. Multiple linear regression model was calculated to predict moderate and severe visual loss; only presenting visual acuity accounted for a unique variance in the model. In conclusion, TNF-α inhibitors achieved rapid disease control while enabling a remarkable steroid-sparing effect in children suffering from chronic uveitis. Presenting visual acuity was the sole predictor of moderate to severe visual loss. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy
- Author
-
Amer, Radgonde, Priel, Ethan, and Kramer, Michal
- Published
- 2015
- Full Text
- View/download PDF
29. Interleukin-17 and its correlation with vascular endothelial growth factor expression in ocular surface pathologies: a histologic study
- Author
-
Solomon, Abraham, Amer, Radgonde, and Jabarin, Basel
- Published
- 2016
- Full Text
- View/download PDF
30. The standardisation of uveitis nomenclature (SUN) project.
- Author
-
Jabs, Douglas A., McCluskey, Peter, Palestine, Alan G., Thorne, Jennifer E., The Standardization of Uveitis Nomenclature Working Group, Accorinti, Massimo, Acharya, Nisha, Amer, Radgonde, Atmaca, Leyla S., Bar, Asaf, Barisani‐Asenbauer, Talin, Becker, Matthias D., Bélair, Marie‐Lyne, Belfort, Rubens, Bhatt, Nirali P., Biswas, Jyotirmay, Blodi, Barbara, Bodaghi, Bahram, Brézin, Antoine P., and Butler, Nicholas J.
- Subjects
UVEITIS ,EYE inflammation ,MACHINE learning ,TRANSLATIONAL research ,IRIDOCYCLITIS - Abstract
The uveitides are a collection of over 30 diseases characterised by intraocular inflammation. Previous work demonstrated that the agreement among uveitis experts on diagnosis was modest at best with some pairs of experts having chance alone agreement on selected diseases. The Standardisation of Uveitis Nomenclature (SUN) is a17‐year collaboration among experts in uveitis, ocular image grading, informatics, and machine learning to improve clinical and translational uveitis research. The SUN "Developing Classification Criteria for the Uveitides" project used a rigorous, multi‐phase approach to develop classification criteria for 25 of the most common uveitic diseases. The project's phases were: (1) informatics; (2) case collection; (3) case selection; (4) machine learning; and (5) consensus review and publication. The results were classification criteria with a high degree of accuracy (93.3%–99.3% depending on anatomic class of the uveitis), the goal of which is to form the basis for future uveitis research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Laser-induced CNV following hair removal procedure
- Author
-
Ioana Teodora Tofolean and Amer Radgonde
- Subjects
hair removal ,medicine.medical_specialty ,Visual acuity ,genetic structures ,Case Reports ,choroidal neovascularization ,law.invention ,Lesion ,diode laser ,chemistry.chemical_compound ,Optical coherence tomography ,law ,Ophthalmology ,Intensive care ,medicine ,medicine.diagnostic_test ,business.industry ,Retinal ,General Medicine ,Fluorescein angiography ,Laser ,eye diseases ,Choroidal neovascularization ,chemistry ,sense organs ,medicine.symptom ,business ,OCTA - Abstract
Objective: To describe the chronological features of choroidal neovascular membrane (CNV) development subsequent to accidental firing of diode laser into the eye of a young female during hair epilation. Methods: Descriptive case report. Results: The patient presented one week after the laser injury to a local ophthalmologist complaining of RE (right eye) blurred central vision. Snellen's visual acuity (VA) was 6/ 7.5. Optical coherence tomography (OCT) showed focal disruption of the ellipsoid and the interdigitation zones. Four weeks later, she presented with worsening symptoms and RE VA 6/ 15. Funduscopy revealed a perifoveal grayish lesion with adjacent retinal hemorrhage, which, on fluorescein angiography, was leaking, compatible with CNV. OCT showed a dome-shaped sub-retinal pigment epithelium lesion with extension into the subretinal space and little subretinal fluid. The patient was treated with one intravitreal bevacizumab injection. There was rapid regression of the CNV and improvement of VA to 6/ 7.5 at one-month visit and to 6/ 6 at 6-month visit. Conclusion: All the laser procedures should be conducted with intensive care for both the patient and the laser surgeon since inadvertent effects are constantly being reported due to lack of adherence to safety measures.
- Published
- 2019
32. Elschnigʼs spots in the acute and remission stages in preeclampsia: spectral-domain optical coherence tomographic features
- Author
-
AlTalbishi, Alaʼa, Khateb, Samer, and Amer, Radgonde
- Published
- 2015
- Full Text
- View/download PDF
33. Sequential spontaneous resolution of acute syphilitic posterior placoid chorioretinitis
- Author
-
Aranda, Sergio and Amer, Radgonde
- Published
- 2015
- Full Text
- View/download PDF
34. Outer Retina Rupture from Subretinal Blood with Spontaneous Sealing and Visual Recovery in Frosted Branch Angiitis from Familial Mediterranean Fever: A Case Report.
- Author
-
Vofo, Brice Nguedia and Amer, Radgonde
- Subjects
- *
VASCULITIS treatment , *STEROID drugs , *RETINA , *TREATMENT effectiveness , *VISUAL acuity , *RETINAL diseases , *VISION disorders , *AUTOINFLAMMATORY diseases , *DISEASE complications - Abstract
Familial Mediterranean fever (FMF) is a rare autoinflammatory disorder. Ocular involvement is rare. The full spectrum and response to treatment is poorly understood. An 18-year-old girl previously diagnosed with FMF presented with sudden loss of vision in the left eye (LE). Best-corrected visual acuity (BCVA) in the LE was finger counting at 1.5 meters. Angiitis with mild "frosting," hemi-central retinal vein occlusion (HCRVO), and acute outer retina rupture (ORR) were observed in the LE. Systemic steroids were initiated immediately. The ORR was sealed 2 weeks later while vision improved to 6/15 (near vision: J2) 5 months later. No recurrences were observed over 5 years of follow-up. We report a rare manifestation of frosted branch angiitis with concomitant HCRVO and ORR in a young patient with FMF. Closure of ORR was attained and vision recovered after treatment with high-dose steroids. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. The association between vitamin D and uveitis: A comprehensive review.
- Author
-
Pillar, Shani and Amer, Radgonde
- Subjects
- *
VITAMIN D , *BEHCET'S disease , *UVEITIS , *INFLAMMATION , *IRIDOCYCLITIS - Abstract
Vitamin D plays an important role in both the innate and adaptive immune systems. We review published data on the relationship between uveitis and vitamin D levels or vitamin D-associated gene polymorphisms. A search of the PubMed and Medline databases was conducted to identify relevant articles concerning vitamin D and uveitis. Sixteen studies were included in this review, and the evidence they present, linking low vitamin D levels with uveitis, is compelling. The uveitic entities shown to be modulated by hypovitaminosis D include, but are not limited to, HLA-B27-associated acute anterior uveitis, Vogt-Koyanagi-Harada (VKH) disease, sarcoidosis-associated uveitis, and juvenile idiopathic arthritis-associated uveitis. Specific polymorphisms of vitamin D family genes were found to correlate with uveitis in ankylosing spondylitis, Behçet's disease, VKH, and HLA B27-positive patients. Further understanding of the role of vitamin D, a known regulator of inflammatory processes, in noninfectious uveitis may advance capabilities in the fields of disease prevention and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults.
- Author
-
Tugal-Tutkun, Ilknur, Onal, Sumru, Stanford, Miles, Akman, Mehmet, Twisk, Jos W.R., Boers, Maarten, Oray, Merih, Özdal, P., Kadayifcilar, Sibel, Amer, Radgonde, Rathinam, Sivakumar R., Vedhanayaki, Rajesh, Khairallah, Moncef, Akova, Yonca, Yalcindag, F., Kardes, Esra, Basarir, Berna, Altan, Çigdem, Özyazgan, Yilmaz, and Gül, Ahmet
- Subjects
IRIDOCYCLITIS ,BEHCET'S disease ,CART algorithms ,UVEITIS ,DIAGNOSIS ,ADULTS - Abstract
Purpose: To develop an algorithm for the diagnosis of Behçet's disease (BD) uveitis based on ocular findings. Methods: Following an initial survey among uveitis experts, we collected multi-center retrospective data on 211 patients with BD uveitis and 207 patients with other uveitides, and identified ocular findings with a high diagnostic odds ratio (DOR). Subsequently, we collected multi-center prospective data on 127 patients with BD uveitis and 322 controls and developed a diagnostic algorithm using Classification and Regression Tree (CART) analysis and expert opinion. Results: We identified 10 items with DOR >5. The items that provided the highest accuracy in CART analysis included superficial retinal infiltrate, signs of occlusive retinal vasculitis, and diffuse retinal capillary leakage as well as the absence of granulomatous anterior uveitis or choroiditis in patients with vitritis. Conclusion: This study provides a diagnostic tree for BD uveitis that needs to be validated in future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Erratum to: Frosted branch angiitis complicated by retinal vein occlusion: clinical course and long-term visual outcome
- Author
-
Greifner, Gabriel, Neri, Piergiorgio, and Amer, Radgonde
- Published
- 2016
- Full Text
- View/download PDF
38. Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study.
- Author
-
Kramer, Michal, Brichova, Michaela, Tugal-Tutkun, Ilknur, Panchenko, Mykola, Gormezano, Natali, Koenigsbauer, Franziska, Franco, Pablo, Muccioli, Cristina, Hasanreisoglu, Murat, International EyeCOPE Study Group, Altan, Ayse Cigdem, Amer, Radgonde, Becker, Matthias, Balta, Florian, Branisteanu, Daniel, Budmann, Gustavo, Silva, Thiago George Cabral, Ozdal, Muge Pinar Cakar, Cekic, Sonja, and Cherecheanu, Alina Popa
- Published
- 2021
- Full Text
- View/download PDF
39. Catastrophic Antiphospholipid Syndrome: Skin, Eye and Brain Involvement.
- Author
-
Sanchez, Juan Martin, Davila, Mauricio, and Amer, Radgonde
- Abstract
To report on a patient with probable catastrophicantiphospholipid syndrome (CAPS) with eye, brain and skin involvement. Descriptive presentation of the case and of the relevant clinical photographs. A 17-year-old girl presented with fatigue, loss of appetite, arthralgia, lower limb skin ulcers and livedo reticularis. Workup showed anemia, elevated ESR, CRP, and positive anti-phospholipid antibodies. Right eye funduscopy showed cotton-wool spots along the inferotemporal arcade with arteriolar occlusion, perivascular retinal hemorrhages, and diffuse retinal ischemia in the temporal peripheral retina. Fluorescein angiogram confirmed the widespread retinal ischemia. Brain MRI revealed several white matter lacunar infarcts, minute cortical/subcortical hemorrhages and subarachnoidal insular hemorrhage. The patient was treated with immunomodulatory therapy, Enoxaparin and retinal laser photocoagulation. Within 2 months of treatment, the facial livedo reticularis resolved and the leg ulcers markedly improved. CAPS causes multiple organ thrombosis and is associated with high rate of mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Psoriasis-associated progressive necrotizing posterior scleritis: A 6-year follow-up.
- Author
-
Amer, Radgonde and Levinger, Nadav
- Published
- 2020
- Full Text
- View/download PDF
41. Demographic and Clinical Features of Pediatric Uveitis in Israel.
- Author
-
Habot-Wilner, Zohar, Tiosano, Liran, Sanchez, Juan M., Shulman, Shiri, Barequet, Dana, Rahat, Ori, Amarilyo, Gil, and Amer, Radgonde
- Subjects
MACROPHAGE activation syndrome ,UVEITIS ,JUVENILE idiopathic arthritis ,VISUAL acuity ,TREATMENT effectiveness ,JUVENILE diseases ,RETROSPECTIVE studies ,DISEASE incidence ,OPTICAL coherence tomography - Abstract
Purpose: To report the epidemiology, etiology, ocular characteristics, treatment and visual outcome of pediatric uveitis in Israel.Methods: Retrospective study from two tertiary uveitis centers.Results: Included were 107 patients (182 eyes), 55% females. Mean age at diagnosis 8.8 years. Uveitis was predominantly anterior, idiopathic, bilateral, and chronic. Systemic associations were seen in 36% of patients of which the most common disease was juvenile idiopathic arthritis. Infectious uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis was the most common cause. Anterior segment complications were commonly observed at presentation (41%); the most predominant were posterior synechiae, cataract, and band keratopathy. The most common posterior segment complications were papillitis, epiretinal membrane, and macular atrophy/scar. Ninety-three percent of eyes had visual acuity >20/40 at last follow-up.Conclusion: The pattern of pediatric uveitis in Israel is similar to that in the western world. Visual outcome was good in most eyes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Subretinal Fibrosis Developing 10 Years After First Presentation with Chronic Ocular Sarcoidosis in a Child.
- Author
-
Mavris, Neofytos, Jaouni, Tarek, and Amer, Radgonde
- Abstract
PurposeMethodsResultsConclusionTo provide a comprehensive overview of the diagnostic and therapeutic journey of a pediatric patient with persistent sarcoid-associated panuveitis over a 10-year period, who ultimately developed bilateral macular subretinal fibrosis and visual loss.Retrospective case reportThe patient was diagnosed with sarcoidosis after undergoing a transbronchial biopsy. She was followed up because of granulomatous panuveitis, multifocal choroiditis, and papillitis bilaterally. She maintained a stable condition, and visual acuity was 0.3 RE and 0.5 LE. Immunomodulatory therapy included prednisone, methotrexate, and adalimumab. The patient was lost to follow-up for 20 months because of the COVID-19 pandemic. She was represented with active uveitis and was not responding to TNF-ɑ inhibitors (adalimumab and infliximab). Ultimately, the patient's intraocular inflammation was successfully controlled by using intravitreal steroids (Triamcinolone and Fluocinolone acetonide implant). However, the visual outcome was guarded because of bilateral subretinal fibrosis.10% of patients with sarcoidosis-associated uveitis risk blindness in one eye. The index case progressed to sight-robbing bilateral subretinal fibrosis, a rare complication of ocular sarcoidosis despite a combination of conventional and biologic anti-inflammatory therapies. There is a pressing need to develop new treatment agents for refractory non-infectious uveitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy.
- Author
-
Pichi, Francesco, Fragiotta, Serena, Bailey Freund, K., Au, Adrian, Lembo, Andrea, Nucci, Paolo, Sebastiani, Stefano, Hernandez, Juan Carlos Gutierrez, Interlandi, Emanuela, Pellegrini, Francesco, Dolz-Marco, Rosa, Gallego-Pinazo, Roberto, Orellana-Rios, Jorge, Adatia, Feisal A., Munro, Monique, Abboud, Emad B., Ghazi, Nicola, Souza, Eduardo Cunha, Amer, Radgonde, and Neri, Piergiorgio
- Abstract
Background/aims To study the multimodal imaging findings of a large series of eyes with cilioretinal artery obstruction (CILRAO) and describe the systemic associations. Methods Multicentre, retrospective chart review from 12 different retina clinics worldwide of eyes with CILRAO, defined as acute retinal whitening in the distribution of the cilioretinal artery, were identified. The clinical, systemic information and multimodal retinal imaging findings were collected and analysed. Results A total of 53 eyes of 53 patients with CILRAO were included in the study. In 100% of eyes, fundus photography illustrated deep retinal whitening corresponding to the course of the cilioretinal artery. Twenty-eight patients (52.8%) presented with isolated CILRAO (baseline best-corrected visual acuity (BCVA) 20/50, final BCVA 20/25) associated with nocturnal hypotension, 23 patients (43.4%) with CILRAO secondary to central retinal vein occlusion (CRVO) (baseline BCVA 20/40, final BCVA 20/20) and two patients with CILRAO due to biopsy-proven giant cell arteritis (GCA) (baseline BCVA 20/175, final BCVA 20/75). With spectral domain optical coherence tomography (SD-OCT), a hyper-reflective band involving the inner nuclear layer (ie, paracentral acute middle maculopathy or PAMM) was noted in 51 eyes (28/28 eyes with isolated CILRAO and 23/23 eyes with CILRAO+CRVO) corresponding to the retinal whitening. In the two eyes with CILRAO+GCA, SD-OCT illustrated hyper-reflective ischaemia of both the middle and inner retina. Conclusions Isolated CILRAO and CILRAO secondary to CRVO are the result of hypoperfusion or insufficiency, rather than occlusion, of the cilioretinal artery and are associated with PAMM or selective infarction of the the inner nuclear layer. With GCA, there is complete occlusion of the cilioretinal artery producing ischaemia involving both the middle and inner retina associated with worse visual outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
44. Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up.
- Author
-
Sancho, Ligia, Koriat, Adi, Amer, Radgonde, Sharon, Yael, Kramer, Michal, and Eiger-Moscovich, Maya
- Abstract
Purpose: To study the prevalence and time of onset of ocular complications in intermediate uveitis (IU) and to assess their effects on visual outcome in short-term and long-term follow-up. Methods: A retrospective cohort study of patients with IU who had a minimal follow-up of one year. Results: 96 patients (174 eyes, 70% females) were included with a mean age at presentation of 30 years. Children constituted 38% of all patients. Mean follow- up was 64.9 months. Pars planitis was the most common form followed by sarcoidosis and multiple sclerosis. Cystoid macular edema (CME), cataract, epiretinal membrane and posterior synechiae were the most prevalent complications. Posterior synechiae, band keratopathy, cataract and papillitis at presentation were associated with worse presenting visual acuity (VA). Of the late-onset complications, glaucoma/ocular hypertension (OHT) was the most significantly associated with worse long-term VA. Most sight-threatening complications (namely CME and glaucoma) were diagnosed at presentation while late complications predominantly affected the posterior segment and included among others peripheral retinal elevations, vasoproliferative tumors, and vitreous hemorrhage. Median LogMAR VA improved at short-term and long-term follow-up, from 0.2 to 0.1 (p<0.001). Subgroup analysis revealed significant VA improvement for eyes with all the different complications except for eyes with glaucoma/OHT. Conclusion: IU is a chronic low-grade uveitis that may be associated with protean early and late complications of the anterior or posterior segments or both. Optimal treatment regimens are imperative for the strict control of inflammation and proper management of complications thus allowing a favorable long-term prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
45. Herpetic Anterior Uveitis - Analysis of Presumed and PCR Proven Cases.
- Author
-
Neumann, Ron, Barequet, Dana, Rosenblatt, Amir, Amer, Radgonde, Ben-Arie-Weintrob, Yael, Hareuveni-Blum, Tamar, Vishnevskia-Dai, Vicktoria, Raskin, Eyal, Blumenfeld, Oren, Shulman, Shiri, Sanchez, Juan M., Flores, Victor, and Habot-Wilner, Zohar
- Subjects
IRIDOCYCLITIS ,POLYMERASE chain reaction ,THERAPEUTICS ,HERPES simplex virus ,HERPESVIRUSES ,ATROPHY ,DNA analysis ,AQUEOUS humor ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,OPHTHALMIC zoster ,EVALUATION research ,RETROSPECTIVE studies ,VIRAL eye infections - Abstract
Purpose: To describe the demographics and clinical characteristics of patients with herpetic anterior uveitis (HAU), and compare characteristics by pathogen, recurrence, and association to iris atrophy.Methods: Multicenter, retrospective study of AU patients diagnosed clinically and by polymerase chain reaction (PCR).Results: The study included 112 eyes in 109 patients: 54 (48.2%) HSV, 34 (30.4%) VZV, 2 (1.8%) CMV, and 22 (19.6%) unspecified diagnosis. HSV eyes, compared to VZV, had a higher recurrence rate, corneal involvement, KPs, iris atrophy, elevated IOP and posterior synechia (p < 0.05). VZV patients had more frequent immunomodulatory treatments and history of systemic herpetic disease (p < 0.05). Fifty-nine (52.7%) eyes had recurrent disease. Iris atrophy was associated with a higher prevalence of posterior synechia, dilated distorted pupil, and high IOP (p < 0.05).Conclusion: Different HAU-causing Herpesviridae produce common clinical findings; therefore, PCR should be used more often to confirm specific diagnosis. Iris atrophy was associated with more severe disease. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
46. Progressive Visual Loss Without Retinal Detachment in Stickler Syndrome: An Uncommon and Novel Presentation.
- Author
-
Navarrete, Ana, Kimchi, Adva, Levy, Jaime, Meiner, Vardiella, Amer, Radgonde, and Yahalom, Claudia
- Subjects
MYOPIA ,RETINAL diseases ,RETINAL detachment ,VISION disorders ,STICKLER syndrome ,DISEASE complications - Abstract
Stickler syndrome is known to cause visual handicap due to the high incidence of retinal detachment. We aim to present an unusual case of a child with Stickler syndrome who had progressive visual loss secondary to atrophy of the outer retinal layers not associated with retinal detachment. This is a descriptive case report of a 9-year-old child with ocular history of high myopia who presented to our institution with suboptimal visual acuity in both eyes. After 2 years of follow up, he developed unilateral progressive visual loss with marked atrophy of the outer retinal layers and peripheral vascular leakage. Such a presentation has not been previously described in the literature to the best of our knowledge. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. The Great Imitator Masquerading as Autoimmune Hepatitis and Demystifying as Fulminant Syphilitic Retinitis.
- Author
-
Kaufman, Ron, Sanchez, Juan Martin, and Amer, Radgonde
- Abstract
PurposeMethodsResultsConclusionSyphilis is a “Great Masquerader” because of its versatile clinical manifestations. We aim to report a patient whose first presentation was with presumed autoimmune hepatitis. Fulminant retinitis subsequently ensued, thus enabling correct diagnosis and treatment.Case description.A 62-year-old male presented with bilateral drop in vision. One month earlier, right eye (RE) arteritic ischemic optic neuropathy was suspected because of severe headache, sudden drop in vision, relative afferent pupillary defect, and elevated inflammatory markers. Systemic steroids were instituted. Brain imaging and temporal artery biopsy were unyielding. Four months earlier, liver biopsy performed because of elevated cholestatic liver enzymes, revealed granulomatous hepatitis. After ruling out viral hepatitis, autoimmune etiology was presumed, and prednisone was started. On presentation, visual acuity (VA) was counting fingers in RE and 6/20 in the left eye (LE). Bilateral panuveitis with punctate inner retinitis, placoid chorioretinitis was diagnosed. Serological tests were strongly positive for syphilis. Lumbar puncture confirmed the existence of neurosyphilis. Systemic penicillin was initiated. One month later, VA improved to RE 6/10, LE 6/7.5, with marked resolution of posterior uveitis. No recurrence was observed over 27-month-period.Acquired syphilitic hepatitis is rarely reported. Administering steroids potentially aggravated the infection. The characteristic features of placoid chorioretinitis and punctate inner retinitis connected the pieces of the puzzle together to the diagnosis of ocular and neurosyphilis. Intrahepatic cholestasis with negative serological panel of hepatotropic pathogens should raise the suspicion of non-hepatotropic pathogens especially syphilis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Cat‐scratch disease: ocular manifestations and treatment outcome.
- Author
-
Habot‐Wilner, Zohar, Trivizki, Omer, Goldstein, Michaella, Kesler, Anat, Shulman, Shiri, Horowitz, Josepha, Amer, Radgonde, David, Ran, Ben‐Arie‐Weintrob, Yael, Bakshi, Erez, Almog, Yehoshua, Sartani, Gil, Vishnevskia‐Dai, Vicktoria, Kramer, Michal, Bar, Asaf, Kehat, Rinat, Ephros, Moshe, and Giladi, Michael
- Subjects
CAT-scratch disease ,HEALTH outcome assessment ,BARTONELLA henselae ,EYE diseases ,UVEITIS ,OPTIC nerve diseases ,FOLLOW-up studies (Medicine) - Abstract
Purpose: To characterize cat‐scratch disease (CSD) ocular manifestations and visual outcome and evaluate the effect of systemic antibiotics and corticosteroids on final visual acuity (VA). Methods: Multicentre retrospective cohort study. Medical records of 86 patients with ocular disease (107 eyes) of 3222 patients identified in a national CSD surveillance study were reviewed. Results: Mean age was 35.1 ± 14.2 years. Median follow‐up was 20 weeks (range 1–806 weeks). Of 94/107 (88%) eyes with swollen disc, 60 (64%) had neuroretinitis at presentation, 14 (15%) developed neuroretinitis during follow‐up, and 20 (21%) were diagnosed with inflammatory disc oedema. Optic nerve head lesion, uveitis, optic neuropathy and retinal vessel occlusion were found in 43 (40%), 38 (36%), 34 (33%) and 8 (7%) eyes, respectively. Good VA (better than 20/40), moderate vision loss (20/40–20/200) and severe vision loss (worse than 20/200) were found in 26/79 (33%), 35/79 (44%) and 18/79 (23%) eyes at baseline and in 63/79 (80%), 11/79 (14%) and 5/79 (6%) eyes at final follow‐up, respectively (p < 0.001). Significant VA improvement (defined as improvement of ≥3 Snellen lines at final follow‐up compared to baseline) occurred in 12/24 (50%) eyes treated with antibiotics compared with 14/16 (88%) eyes treated with antibiotics and corticosteroids (p = 0.02). Multivariate logistic regression was suggestive of the same association (odds ratio 7.0; 95% CI 1.3–37.7; p = 0.024). Conclusion: Optic nerve head lesion is a common and unique manifestation of ocular CSD. Most patients improved and had final good VA. Combined antibiotics and corticosteroid treatment was associated with a better visual outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
49. Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression.
- Author
-
Sharon, Yael, Friling, Ronit, Luski, Moshe, Campoverde, Belén Quizhpe, Amer, Radgonde, and Kramer, Michal
- Subjects
GLAUCOMA ,UVEITIS ,INTRAOCULAR pressure ,IMMUNOREGULATION ,HEALTH outcome assessment ,DISEASE progression ,DISEASE risk factors ,GLAUCOMA diagnosis ,THERAPEUTIC use of glucocorticoids ,COMPARATIVE studies ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,VISUAL acuity ,VISUAL fields ,EVALUATION research ,TREATMENT effectiveness ,RETROSPECTIVE studies ,OCULAR hypertension ,DISEASE complications ,DIAGNOSIS - Abstract
Purpose: To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression.Methods: Retrospective study of uveitic glaucoma patients in two tertiary medical centers in 2003-2015. Patient- and disease-related data was retrieved. Clinical parameters and visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure ≤21 mmHg and preserving visual fields.Results: Included were 34 patients (53 eyes), with a mean follow-up of 7 years. Idiopathic anterior uveitis and open-angle glaucoma were most common. In total, 62% of eyes were steroid responders. Higher IOP was associated with posterior synechiae, peripheral-anterior synechiae, steroidal, and immunomodulatory therapy (p<0.05). Glaucomatous field defects developed in 49%, with most showing no progression, despite elevation of cup-to-disc ratio (p<0.05).Conclusions: Chronic severe uveitis, expressed by structural complications and immunomodulatory therapy, was associated with high IOP and the need for more IOP lowering medications, but was unrelated to glaucomatous damage. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
50. Exudative retinal detachment.
- Author
-
Amer, Radgonde, Nalcı, Hilal, and Yalçındağ, Nilüfer
- Subjects
- *
RETINAL detachment , *ADRENOCORTICAL hormones , *IMMUNOSUPPRESSION , *OPTICAL coherence tomography , *RETINAL anatomy - Abstract
Exudative retinal detachment develops when fluid collects in the subretinal space. The subretinal space between the photoreceptors and the retinal pigment epithelium is the remnant of the embryonic optic vesicle. In the developed eye the subretinal space is of minimal size, but it can reopen under pathological conditions that disrupt the integrity of blood-retinal barrier. Inflammatory, infectious, infiltrative, neoplastic, vascular, and degenerative conditions may be associated with blood-retinal barrier breakdown and the sequential development of exudative retinal detachment. We elaborate on the pathogenesis and the differential diagnosis of exudative retinal detachment and specifically discuss the spectrum of diseases associated with exudative retinal detachment in uveitis clinics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.